Camille MacMillin/STAT

What happened to Covid?

Experts analyze why Covid severity has declined, who still benefits from booster shots, and if a once-feared virus is now more like plain old colds or flu.

By Helen Branswell

STAT+ | Dems say RFK Jr. has a pattern of failing to answer their questions

There's not much Democrats can do if RFK Jr. doesn't answer their questions or follow through on pledges.

By Daniel Payne

Trump administration warns against using federal dollars on fentanyl test strips

Trump administration, which slashed SAMHSA funding and staff last year, bans funding of clean syringes or drug test strips, issues new warning on MOUD use.

By Lev Facher

Adobe

STAT+ | Veradermics’ hair loss drug succeeds in late-stage trial

The company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm.

By Allison DeAngelis

NIH-funded research lags in reporting sex differences, new study finds

Northwestern University study finds 61% of NIH-funded papers included both sexes, but only 44% reported results by sex.

By Annalisa Merelli and Anil Oza

STAT+ | Zap in a cap: How one neurotech startup is using a hat to treat depression

Motif Neurotech's CEO on getting FDA green light to start an initial feasibility trial to test a brain implant that targets treatment-resistant depression.

By O. Rose Broderick

Adobe

Opinion: Patients seeking mental health treatment are not commodities

Legal agreements that directly shape access to care to remain invisible to the very people whose lives they govern.

By Sarah Cady

Opinion: I’m a fourth-year med student, but I only learned one historical example of medical racism

Modern randomized controlled trials often rely on marginalized populations abroad.

By Uzma Rentia